Estevan Kiernan

Estevan Kiernan is a seasoned professional with extensive experience in oncology and molecular pathology. Currently serving as the MRD Global Franchise Lead at Illumina since February 2017, Estevan has held multiple leadership roles, including Associate Director and Sr. Manager in Emerging Clinical Applications. As a Board Member of the Strategic Opportunities Committee for the Association for Molecular Pathology and as Co-Chair for the Regulatory Steering Committee at GUIDE.MRD, Estevan actively contributes to industry advancements. Estevan has also co-chaired the Reimbursement and Policy Working Group for BLOODPAC and serves on the Advisory Board at Texas Tech University Health Sciences Center. Estevan's earlier experience includes roles at Abbott, the College of American Pathologists, Thermo Fisher Scientific, and Nostics Consulting. Estevan holds a Bachelor of Science in Microbiology and a Master of Science in Molecular Pathology from Texas Tech University.